Kuros Biosciences AG (LON:0RHR)

Market Cap	1.11B
Revenue (ttm)	94.85M
Net Income (ttm)	-5.57M
Shares Out	n/a
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	85.89
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,832
Average Volume	27,978
Open	30.51
Previous Close	29.06
Day's Range	29.76 - 30.53
52-Week Range	15.70 - 34.08
Beta	0.92
RSI	56.13
Earnings Date	Mar 10, 2026

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bon...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Employees: 122
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RHR

Financial Performance

In 2024, Kuros Biosciences AG's revenue was 75.56 million, an increase of 125.11% compared to the previous year's 33.56 million. Losses were -4.29 million, -68.75% less than in 2023.

Financial numbers in CHF